Stock Price
14.33
Daily Change
-0.27 -1.84%
Monthly
4.68%
Yearly
25.36%
Q1 Forecast
14.47

Amarin reported $184.7M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amarin USD 184.7M 13.46M Sep/2025
AstraZeneca USD 6.59B 126M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025